{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:02:41Z","timestamp":1782781361888,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cmi.2023.07.026","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T11:45:04Z","timestamp":1690803904000},"page":"1450.e1-1450.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis"],"prefix":"10.1016","volume":"29","author":[{"given":"Eleftheria","family":"Kampouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danniel","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika S.","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ibrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Blazevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika A.","family":"Lovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meei-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Ueda Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Boeckh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.07.026_bib1","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bbmt.2012.05.012","article-title":"HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation","volume":"18","author":"Zerr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib2","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2012.04.016","article-title":"Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis","volume":"18","author":"Hill","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/bmt.2017.175","article-title":"Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Ogata","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jaci.2016.12.992","article-title":"Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation","volume":"140","author":"Admiraal","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.cmi.2023.07.026_bib5","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.bbmt.2018.04.021","article-title":"Human herpesvirus-6B reactivation is a risk factor for grades II to IV acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"24","author":"Phan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib6","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.19.00908","article-title":"Human herpesvirus 6B and lower respiratory tract disease after hematopoietic cell transplantation","volume":"37","author":"Hill","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cmi.2023.07.026_bib7","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood-2014-12-617035","article-title":"Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies","volume":"125","author":"Seo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2023.07.026_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/428060","article-title":"Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation","volume":"40","author":"Zerr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.026_bib9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/cid\/cix804","article-title":"Kinetics of double-stranded DNA viremia after allogeneic hematopoietic cell transplantation","volume":"66","author":"Hill","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.026_bib10","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.bbmt.2018.07.033","article-title":"High incidence of early human herpesvirus-6 infection in children undergoing haploidentical manipulated stem cell transplantation for hematologic malignancies","volume":"24","author":"Perruccio","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib11","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2022009274","article-title":"Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients","author":"Noviello","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.cmi.2023.07.026_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jtct.2021.09.015","article-title":"Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome","volume":"28","author":"Singh","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2023.07.026_bib13","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2023.07.026_bib14","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3324\/haematol.2019.223073","article-title":"Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation","volume":"104","author":"Ward","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2023.07.026_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.bmt.1705617","article-title":"Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients","volume":"39","author":"Ljungman","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.bbmt.2018.02.008","article-title":"Effects of prophylactic foscarnet on human herpesvirus-6 reactivation and encephalitis in cord blood transplant recipients: a prospective multicenter trial with an historical control group","volume":"24","author":"Ogata","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib17","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood.2019004315","article-title":"Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT","volume":"135","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2023.07.026_bib18","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.026_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","article-title":"American Society for Transplantation and Cellular Therapy Series: #3\u2014prevention of cytomegalovirus infection and disease after hematopoietic cell transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2023.07.026_bib20","first-page":"2062","article-title":"How I prevent viral reactivation in high-risk patients","volume":"141","author":"Dadwal","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2023.07.026_bib21","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.07.026_bib22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1056\/NEJMc1406756","article-title":"CMV prophylaxis in hematopoietic-cell transplantation","volume":"371","author":"Chemaly","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.07.026_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/cid\/ciab1064","article-title":"Impact of letermovir primary cytomegalovirus prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation: a retrospective cohort study","volume":"75","author":"Su","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.026_bib24","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/cid\/ciab298","article-title":"Refractory and resistant cytomegalovirus after hematopoietic cell transplant in the letermovir primary prophylaxis era","volume":"73","author":"Sassine","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.026_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41409-023-01920-w","article-title":"Cytomegalovirus breakthrough and resistance during letermovir prophylaxis","volume":"58","author":"Perchetti","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jtct.2022.06.016","article-title":"Clinical and economic burden of multiple double-stranded DNA viral infections after allogeneic hematopoietic cell transplantation","volume":"28","author":"Hill","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2023.07.026_bib27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/vaccines9040372","article-title":"Letermovir primary prophylaxis in high-risk hematopoietic cell transplant recipients: a matched cohort study","volume":"9","author":"Royston","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cmi.2023.07.026_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/bmt.2009.116","article-title":"Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients","volume":"45","author":"Ogata","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib29","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.transproceed.2005.03.123","article-title":"Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients","volume":"37","author":"Galarraga","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cmi.2023.07.026_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9856","article-title":"Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function","volume":"6","author":"Sen","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.cmi.2023.07.026_bib32","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2009.02824.x","article-title":"The \u2018indirect\u2019 effects of cytomegalovirus infection","volume":"9","author":"Freeman","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2023.07.026_bib33","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood-2015-03-631853","article-title":"CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR\u03b2 repertoire","volume":"125","author":"Suessmuth","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2023.07.026_bib34","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2015-04-640664","article-title":"CMV after transplant: T-cell repertoire crooks","volume":"125","author":"Meyer","year":"2015","journal-title":"Blood"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23003543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23003543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:35:21Z","timestamp":1761118521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23003543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1198743X23003543"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.07.026","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}